Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 193

1.

Growth hormone therapy in children born small for gestational age: results from the ANSWER program.

Rapaport R, Lee P, Ross J, Saenger P, Ostrow V, Piccoli G.

Endocr Connect. 2018 Aug 23. pii: EC-18-0286. doi: 10.1530/EC-18-0286. [Epub ahead of print]

2.

Long-Acting Growth Hormone in Idiopathic Short Stature.

Saenger P, Zamora-Siliezar L.

Horm Res Paediatr. 2018;90(1):64-65. doi: 10.1159/000490115. Epub 2018 Jul 12. No abstract available.

3.

Feeling misguided: a comment on the US guidelines on growth hormone and insulin-like growth factor-I treatment in children and adolescents.

Saenger P, Cohen P.

Curr Opin Pediatr. 2017 Aug;29(4):472-474. doi: 10.1097/MOP.0000000000000520. No abstract available.

PMID:
28604412
4.

Ten years of biosimilar recombinant human growth hormone in Europe.

Saenger P.

Drug Des Devel Ther. 2017 May 16;11:1505-1507. doi: 10.2147/DDDT.S130317. eCollection 2017. Review.

5.

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations.

Christiansen JS, Backeljauw PF, Bidlingmaier M, Biller BM, Boguszewski MC, Casanueva FF, Chanson P, Chatelain P, Choong CS, Clemmons DR, Cohen LE, Cohen P, Frystyk J, Grimberg A, Hasegawa Y, Haymond MW, Ho K, Hoffman AR, Holly JM, Horikawa R, Höybye C, Jorgensen JO, Johannsson G, Juul A, Katznelson L, Kopchick JJ, Lee KO, Lee KW, Luo X, Melmed S, Miller BS, Misra M, Popovic V, Rosenfeld RG, Ross J, Ross RJ, Saenger P, Strasburger CJ, Thorner MO, Werner H, Yuen K.

Eur J Endocrinol. 2016 Jun;174(6):C1-8. doi: 10.1530/EJE-16-0111. Epub 2016 Mar 23.

6.

Long-Acting Growth Hormone: An Update.

Saenger PH, Mejia-Corletto J.

Endocr Dev. 2016;30:79-97. doi: 10.1159/000439333. Epub 2015 Dec 10. Review.

PMID:
26683877
7.

GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.

Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P, Butler G, Chihara K, Christiansen J, Cianfarani S, Clayton P, Clemmons D, Cohen P, Darendeliler F, Deal C, Dunger D, Erfurth EM, Fuqua JS, Grimberg A, Haymond M, Higham C, Ho K, Hoffman AR, Hokken-Koelega A, Johannsson G, Juul A, Kopchick J, Lee P, Pollak M, Radovick S, Robison L, Rosenfeld R, Ross RJ, Savendahl L, Saenger P, Toft Sorensen H, Stochholm K, Strasburger C, Swerdlow A, Thorner M.

Eur J Endocrinol. 2016 Feb;174(2):P1-9. doi: 10.1530/EJE-15-0873. Epub 2015 Nov 12.

8.

Sodium/Iodide Symporter Mutant V270E Causes Stunted Growth but No Cognitive Deficiency.

Nicola JP, Reyna-Neyra A, Saenger P, Rodriguez-Buritica DF, Gamez Godoy JD, Muzumdar R, Amzel LM, Carrasco N.

J Clin Endocrinol Metab. 2015 Oct;100(10):E1353-61. doi: 10.1210/jc.2015-1824. Epub 2015 Jul 23.

9.

The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.

Sosenko JM, Skyler JS, Beam CA, Boulware D, Mahon JL, Krischer JP, Greenbaum CJ, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups.

Diabetes Care. 2015 May;38(5):940-2. doi: 10.2337/dc14-2787. Epub 2015 Mar 10.

10.

Erratum to: Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System.

Rashid N, Saenger P, Wu YL, Woehling H, Frankel M, Lifshitz F, Muenzberg M, Rapaport R.

Biol Ther. 2014 Dec;4(1-2):81. doi: 10.1007/s13554-014-0020-6. No abstract available.

11.

Switching to Omnitrope(®) from Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System.

Rashid N, Saenger P, Wu YL, Woehling H, Frankel M, Lifshitz F, Muenzberg M, Rapaport R.

Biol Ther. 2014 Dec;4(1-2):27-39. doi: 10.1007/s13554-014-0017-1. Epub 2014 Aug 6. Erratum in: Biol Ther. 2014 Dec;4(1-2):81.

12.

Clinical characteristics and chromosome 11p15 imprinting analysis of Silver-Russell syndrome - a Chinese experience.

Wu D, Gong C, Zheng H, Saenger P, Zhao Y, Gu Y, Cao B, Li W, Su C.

J Pediatr Endocrinol Metab. 2014 Nov;27(11-12):1113-20. doi: 10.1515/jpem-2013-0490.

PMID:
24945423
13.

Trends in the incidence of childhood type 1 diabetes mellitus in Beijing based on hospitalization data from 1995 to 2010.

Gong C, Meng X, Saenger P, Wu D, Cao B, Wu D, Wei L.

Horm Res Paediatr. 2013;80(5):328-34. doi: 10.1159/000355388. Epub 2013 Nov 6.

PMID:
24216776
14.

24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency.

Khadilkar V, Radjuk KA, Bolshova E, Khadgawat R, El Kholy M, Desai M, Peterkova V, Mericq V, Kratzsch J, Siepl EC, Martin D, Lopez P, Ji HJ, Bae YJ, Lee JH, Saenger PH.

J Clin Endocrinol Metab. 2014 Jan;99(1):126-32. doi: 10.1210/jc.2013-2502. Epub 2013 Dec 20.

PMID:
24170106
15.

Domestic global health: a curriculum teaching medical students to evaluate refugee asylum seekers and torture survivors.

Asgary R, Saenger P, Jophlin L, Burnett DC.

Teach Learn Med. 2013;25(4):348-57. doi: 10.1080/10401334.2013.827980.

PMID:
24112205
16.

Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study.

Rapaport R, Saenger P, Schmidt H, Hasegawa Y, Colle M, Loche S, Marcantonio S, Bonfig W, Zabransky M, Lifshitz F.

Med Devices (Auckl). 2013 Sep 2;6:141-6. doi: 10.2147/MDER.S50088. eCollection 2013.

17.

Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.

Sosenko JM, Skyler JS, Beam CA, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups.

Diabetes. 2013 Dec;62(12):4179-83. doi: 10.2337/db13-0656. Epub 2013 Jul 17.

18.

The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients.

Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2013 Sep;36(9):2615-20. doi: 10.2337/dc13-0425. Epub 2013 Jul 1.

19.

Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients.

Hartman ML, Xu R, Crowe BJ, Robison LL, Erfurth EM, Kleinberg DL, Zimmermann AG, Woodmansee WW, Cutler GB Jr, Chipman JJ, Melmed S; International HypoCCS Advisory Board.

J Clin Endocrinol Metab. 2013 Mar;98(3):980-8. doi: 10.1210/jc.2012-2684. Epub 2013 Jan 23.

20.

Turner syndrome: strategies to improve care outcomes. Foreword.

Saenger P, Bondy C.

Pediatr Endocrinol Rev. 2012 May;9 Suppl 2:696-7. No abstract available.

PMID:
22946278

Supplemental Content

Loading ...
Support Center